Psilocybin in Adults With and Without Autism Spectrum Disorder

Completed 67 enrolled King's College London University of Cambridge · collab

RandomizedCrossoverDouble-blindBasic science

Summary

This study will test the hypothesis that brain systems are differentially regulated by serotonin in individuals with and without Autism Spectrum Disorder.

Timeline

Start: 2022-12-12
Primary completion: 2024-08-23
Completion: 2024-08-23

Publications

Whelan TP, Daly E, Puts NA, Smith P, Allison C, Baron-Cohen S, Malievskaia E, Murphy DGM, McAlonan GM. The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin. BMC Psychiatry. 2024 Apr 25;24(1):319. doi: 10.1186/s12888-024-05768-2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Psilocybin	Other / unclassified	2 mg	—
Subject	Psilocybin	Other / unclassified	5 mg	—

Psilocybin in Adults With and Without Autism Spectrum Disorder

Summary

Timeline

Publications

Drugs

Indications